Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|October 13, 2006
Glutathione S-transferase polymorphisms and onset age in alpha-synuclein A53T mutant Parkinson's diseaseLawrence I Golbe, Giuseppe Di Iorio, Katerina Markopoulou, et al.
Parkinsonism & Related Disorders|September 29, 2020
Video-tutorial for the Movement Disorder Society criteria for progressive supranuclear palsyVassilena Iankova, Gesine Respondek, Gerard Saranza, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 1, 2022
A Modified Progressive Supranuclear Palsy Rating Scale for Virtual AssessmentsAnne-Marie Wills, Alexander Pantelyat, Alberto Espay, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 7, 2016
Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degenerationMonica Sanchez-Contreras, Michael G Heckman, Pawel Tacik, et al.
Neurology. Clinical Practice|August 26, 2024
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders: A Consensus StatementMichiko K Bruno, Rohit Dhall, Antoine Duquette, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 14, 2017
Radiological biomarkers for diagnosis in PSP: Where are we and where do we need to be?Jennifer L Whitwell, Günter U Höglinger, Angelo Antonini, et al.
Acta Neuropathologica Communications|June 1, 2023
Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degenerationShunsuke Koga, Michael A Metrick, Lawrence I Golbe, et al.
Frontiers in Neurology|January 8, 2025
Montreal cognitive assessment as a cognitive outcome measure in progressive supranuclear palsyVanessa Ibrahim, Catherine Isroff, Christopher D Stephen, et al.
Cell|July 16, 2011
Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutationsFrank Soldner, Josée Laganière, Albert W Cheng, et al.
Nature Medicine|August 13, 2021
Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trialTien Dam, Adam L Boxer, Lawrence I Golbe, et al.
Pageof 5